Cancer drug developer Viracta Therapeutics said Tuesday it has raised $10 million as part of a larger financing that is still in progress.
The Encinitas company got the money from Chinese drug company Salubris, the lead investor. Salubris and Viracta have also agreed to bring Viracta?s treatment…
